Aktiespot

IOL Chemicals and Pharmaceuticals Limited (IOL CHEM AND PHARMA LTD) Aktie

IOLCP.NS

₹130.97-0.45 (-0.34%)
Chart wird geladen...
IOL CHEM AND PHARMA LTD Logo

IOL CHEM AND PHARMA LTD

Eröffnung130.90
Hoch134.29
Tief128.65
Volumen1.77M
P/E27.99
Marktkapitalisierung38.44B
52-Wochen-Hoch138.90
52-Wochen-Tief67.19
Durchschn. Volumen3.49M
Dividende0.76%
Beta0.27
EPS4.68

Über IOL Chemicals and Pharmaceuticals Limited (IOL CHEM AND PHARMA LTD) Aktie

IOL Chemicals and Pharmaceuticals Limited manufactures and sells pharmaceutical and chemical products in India and internationally. The company operates through, Chemical and Pharmaceutical segments. The Chemical segment offers ethyl acetate, iso butyl benzene, acetyl chloride, mono chloro acetic acid, and acetic anhydride to food processing, flexible packaging, pharmaceuticals, textiles, ink, paint, pesticides, and chemical intermediates industries. The Pharmaceutical segment provides active pharmaceutical ingredients, such as ibuprofen, metformin, fenofibrate, lamotrigine, clopidogrel bisulphate, pantoprazole sodium, ursodeoxycholic acid, losartan potassium, gabapentin, levetiracetam, and paracetamol. Its active pharmaceutical ingredients are used for the treatment of anti-inflammatory, analgesic and antipyretic, anti-diabetic, anti- platelet, anti-cholesterol, anti- convulsant, anti-epileptic, anti-hypertensive, and anti-cholelithic, as well as proton pump inhibitor. IOL Chemicals and Pharmaceuticals Limited was incorporated in 1986 and is based in Ludhiana, India.

Unternehmensinformationen

Börse: NSE (NSI)
Sektor: Sundhed
Branche: Lægemiddelproducenter – Special og generisk
Adresse:
85, Industrial Area 'A'
141003 Ludhiana, India
Telefon: + 91 16 1222 5531

Analystenempfehlungen

Diese Übersicht gibt einen schnellen Einblick, wie Analysten das Aktienpotenzial basierend auf ihren neuesten Analysen und Kurszielen bewerten.

Anbefaling:1.00 - Stærk køb
Niedrigstes Kursziel
150.00
14.5%
Durchschnittliches Kursziel
150.00
14.5%
Median Kursziel
150.00
14.5%
Höchstes Kursziel
150.00
14.5%

Andere sehen auch: